Skip to content

Graft Bone Substitute

by PURGO BIOLOGICS Inc.

510(k) K191737

Active European Union and United States

CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK191737 Date14 Feb 2020ClearedStatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
28 Jun 2019
FDA decision
14 Feb 2020 (Substantially Equivalent)
FDA review time
231 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K191737 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K191737 decided 14 Feb 2020 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

Full name
The Graft Bone Substitute
510(k) Number
FDA product code
NPM
FDA applicant
Purgo Biologics, Inc.
Device class
Class II
Regulation
21 CFR Part 872.3930
Advisory committee
Dental
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Graft Bone Substitute is a Bone Grafting Material, Animal Source, designed to promote bone regeneration and repair in dental procedures. It serves as an alternative to autogenous bone grafts by providing a scaffold and growth factors to support new bone formation in defects or extraction sites.

This material is supplied as a sterile, single-use product and is intended for use in dental settings. It is classified as a Class II medical device under FDA regulations and has received FDA 510K clearance and MDD compliance. Multiple lot numbers and registration identifiers confirm its regulatory authorisation for dental bone grafting applications, with no MRI safety restrictions specified.

Devices cleared under K191737

6 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K191737
UDI-DISize and differences
THE Graft TG-AS05
PURGO BIOLOGICS Inc.
TG-AS0508800039000130 —On the market
THE Graft TG-AS10
PURGO BIOLOGICS Inc.
TG-AS1008800039000147 —On the market
THE Graft TG-AS25
PURGO BIOLOGICS Inc.
TG-AS2508800039000123 —On the market
THE Graft TG-BS05
PURGO BIOLOGICS Inc.
TG-BS0508800039000284 —On the market
THE Graft TG-BS10
PURGO BIOLOGICS Inc.
TG-BS1008800039000291 —On the market
THE Graft TG-BS25
PURGO BIOLOGICS Inc.
TG-BS2508800039000277 —On the market

Similar devices

Other devices filed under FDA product code NPM (Bone Grafting Material, Animal Source).

Other devices from PURGO BIOLOGICS Inc.

See all devices from PURGO BIOLOGICS Inc. →